Rabies Virus Glycoprotein TFA
Rabies Virus Glycoprotein TFA
Rabies Virus Glycoprotein TFA, an absolutely pivotal pharmaceutical constituent, is extensively applied in manufacturing vaccines that specifically combat the ruthless manifestations resulting from infections caused by the rabies virus. By effectively enabling the initiation of protective immunological reactions targeting the viral glycoprotein, this extraordinary entity plays a paramount role in mitigating and managing the dire consequences associated with the pernicious rabies affliction.
Online Inquiry
| CAT# | GR2201 |
| M.F/Formula | C143H218N43F3O45S |
| M.W/Mr. | 3380.72 |
| Appearance | Solid |
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Write a review
Ask a question
My Review for Rabies Virus Glycoprotein TFA
Required fields are marked with *
×
Ask a Question for Rabies Virus Glycoprotein TFA
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
